Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance

E-ISSN： 1349-7006|109|1|94-102

ISSN： 1347-9032

Source： Cancer Science, Vol.109, Iss.1, 2018-01, pp. : 94-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exosomes in development, metastasis and drug resistance of breast cancer

Cancer Science, Vol. 106, Iss. 8, 2015-08 ,pp. : 959-964

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic advances in BIG3‐PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 550-558

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor‐1α that enhances CoCl2‐induced doxorubicin resistance in breast cancer cells

Cancer Science, Vol. 106, Iss. 8, 2015-08 ,pp. : 1041-1049

John Wiley & Sons Inc

Access to resources Recommend Favorite

ASC amino acid transporter 2, defined by enzyme‐mediated activation of radical sources, enhances malignancy of GD2‐positive small‐cell lung cancer

Cancer Science, Vol. 109, Iss. 1, 2018-01 ,pp. : 141-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

In Vitro Release Characteristics of Hydrophobic Breast Cancer Drug Loaded Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles

Advanced Materials Research, Vol. 2015, Iss. 1123, 2015-09 ,pp. : 312-315

Trans Tech Publications

Access to resources Recommend Favorite